ID   NCC-GCTB9-C1
AC   CVCL_D4C1
DR   Wikidata; Q127382930
RX   PubMed=38466561;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Can be grown as spheroids (PubMed=38466561).
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 12 hours (PubMed=38466561).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=38466561).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone, distal tibia; UBERON=UBERON_0004405.
ST   Source(s): PubMed=38466561
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 32
ST   D5S818: 9,13
ST   D7S820: 8,11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
RX   PubMed=38466561; DOI=10.1007/s13577-024-01042-5;
RA   Adachi Y., Noguchi R., Yoshimatsu Y., Sin Y., Osaki J., Ono T.,
RA   Iwata S., Akiyama T., Tsuchiya R., Toda Y., Ishihara S., Ogura K.,
RA   Kobayashi E., Kojima N., Yoshida A., Yokoo H., Kawai A., Kondo T.;
RT   "Establishment and characterization of two novel patient-derived cell
RT   lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.";
RL   Hum. Cell 37:874-885(2024).
//